Latest Breaking News On - Tetravalent immunisation - Page 1 : comparemela.com

A dengue vaccine candidate developed by Takeda Pharmaceutical (Takeda), TAK-003, has shown promising results in a Phase 3 trial, providing continued

United statesDuane gublerEllyana ismailThomas willemsenAsia pacificHead of medical affairsTakeda pharmaceuticals asia pacificSignature research programme atEuropean unionTakeda pharmaceuticalTetravalent immunisationDengue efficacy studyProfessor duane gublerEmeritus professorFounding directorEmerging infectious diseases